Zenith Biosciences And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-12-2024
- Paid Up Capital ₹ 0.60 M
as on 08-12-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -8.49%
(FY 2022)
- Profit -84.82%
(FY 2022)
- Ebitda -3164.81%
(FY 2022)
- Net Worth 3.88%
(FY 2022)
- Total Assets -10.42%
(FY 2022)
About Zenith Biosciences And Research Centre
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Shukla, Shashi Singh, and Chandan Mishra serve as directors at the Company.
- CIN/LLPIN
U24232BR2013PTC019900
- Company No.
019900
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Feb 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Zenith Biosciences And Research Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Shukla  | Director | 22-Feb-2013 | Current |
| Shashi Singh | Director | 22-Feb-2013 | Current |
| Chandan Mishra | Director | 22-Feb-2013 | Current |
Financial Performance of Zenith Biosciences And Research Centre.
Zenith Biosciences And Research Centre Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.49% decrease. The company also saw a substantial fall in profitability, with a 84.82% decrease in profit. The company's net worth moved up by a moderate rise of 3.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenith Biosciences And Research Centre?
In 2021, Zenith Biosciences And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Acuvae Parenterals Private LimitedActive 5 years 18 days
Rajiv Shukla, Shashi Singh and 1 more are mutual person
- Gravis Parenterals Private LimitedActive 5 years 20 days
Rajiv Shukla, Shashi Singh and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zenith Biosciences And Research Centre?
Unlock and access historical data on people associated with Zenith Biosciences And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenith Biosciences And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenith Biosciences And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
